comparemela.com

Latest Breaking News On - Bruder consulting venture group - Page 2 : comparemela.com

CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS

EXCLUSIVE: Data Monitoring Committee Allows BioRestorative s Chronic Lumbar Disc Disease Study To Continue Unchanged - BioRestorative Therapies (NASDAQ:BRTX)

BioRestorative Therapies Inc (NASDAQ: BRTX) has announced that the independent Data Safety Monitoring Board (DSMB), overseeing the company's ongoing Phase 2 trial to treat chronic lumbar disc disease, unanimously recommended the continuation of the study under the current version of the protocol wi

ChitogenX Inc pursuing new strategic development partnerships

ChitogenX Inc pursuing new strategic development partnerships
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Speaker: Biologic use, promotional material need to be in alignment with on label use

LAS VEGAS — As the business of biologic products has continued to grow, scrutiny from the FDA and other federal authorities on the use and promotion of biologics has also increased, according to a speaker. Although the FDA provides physicians with guidance on the use of biologics, Scott P. Bruder, MD, PhD, noted the agency does not regulate the practice of medicine.

Biorestorative Therapies (BRTX) to Seek FDA Approval to Expand the Clinical Application of BRTX-100

Biorestorative Therapies (BRTX) to Seek FDA Approval to Expand the Clinical Application of BRTX-100
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.